cyclosporine and Papulosquamous Disorders

cyclosporine has been researched along with Papulosquamous Disorders in 8 studies

Research

Studies (8)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (25.00)18.2507
2000's5 (62.50)29.6817
2010's1 (12.50)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Dong, H; Hu, S; Ma, R; Wang, C; Wang, W; Xiao, Z1
Chau, YP; Pang, SM1
Luger, T; Metze, D; Pullmann, S1
Dijkmans, BA; Finlay, AY; Griffiths, CE; Ho, VC; Johnston, A; Katsambas, A; Luger, TA; Mrowietz, U; Thestrup-Pedersen, K1
Begueret, H; Beylot, C; Beylot-Barry, M; Doutre, MS; Dromer, C; Leyral, C; Vergier, B1
Hatta, N; Imai, T; Sakai, H; Takata, M; Takehara, K; Tsutsui, K1
Avci, O; Guneş, AT; Izler, F; Pabuçcuoğlu, U; Sahin, T1
Henderson, CA; Sommer, S1

Reviews

1 review(s) available for cyclosporine and Papulosquamous Disorders

ArticleYear
Update on the use of ciclosporin in immune-mediated dermatoses.
    The British journal of dermatology, 2006, Volume: 155 Suppl 2

    Topics: Arthritis, Psoriatic; Cyclosporine; Dermatitis, Atopic; Humans; Immunosuppressive Agents; Patient Selection; Psoriasis; Quality of Life; Skin Diseases; Skin Diseases, Papulosquamous

2006

Other Studies

7 other study(ies) available for cyclosporine and Papulosquamous Disorders

ArticleYear
Langerhans cell histiocytosis presenting as a multi-system disorder in an infant.
    International journal of dermatology, 2012, Volume: 51, Issue:6

    Topics: Biopsy; Bone Diseases; Cyclosporine; Femur; Glucocorticoids; Histiocytosis, Langerhans-Cell; Humans; Immunosuppressive Agents; Infant; Lung Diseases; Male; Mercaptopurine; Methotrexate; Methylprednisolone; Prednisone; Radiography; Skin; Skin Diseases, Papulosquamous

2012
Cyclosporin-induced sebaceous hyperplasia in renal transplant patients.
    Annals of the Academy of Medicine, Singapore, 2005, Volume: 34, Issue:5

    Topics: Adult; Cyclosporine; Face; Humans; Hyperplasia; Immunosuppressive Agents; Kidney Transplantation; Male; Middle Aged; Sebaceous Glands; Skin Diseases, Papulosquamous

2005
[Papuloerythroderma of Ofuji with urticarial lesions].
    Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG, 2004, Volume: 2, Issue:6

    Topics: Adrenal Cortex Hormones; Aged; Cyclosporine; Dermatitis, Exfoliative; Humans; Immunosuppressive Agents; Male; Paraneoplastic Syndromes; Skin Diseases, Papulosquamous; Urticaria

2004
[Cyclosporine-induced follicular eruption].
    Annales de dermatologie et de venereologie, 2008, Volume: 135, Issue:1

    Topics: Adult; Cyclosporine; Humans; Immunocompromised Host; Immunosuppressive Agents; Lung Transplantation; Male; Skin Diseases, Papulosquamous

2008
Widespread pruritic plaques in a patient with subacute cutaneous lupus erythematosus and hypocomplementemia: response to dapsone therapy.
    Journal of the American Academy of Dermatology, 1996, Volume: 35, Issue:2 Pt 2

    Topics: Adult; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Chloroquine; Complement C3; Complement System Proteins; Cyclosporine; Dapsone; Dermatologic Agents; Female; Humans; Immunoglobulin G; Immunoglobulin M; Immunosuppressive Agents; Lupus Erythematosus, Cutaneous; Methylprednisolone; Prednisolone; Pruritus; Skin Diseases, Papulosquamous

1996
Effective treatment of persistent papular acantholytic dermatosis with cyclosporine.
    Journal of the European Academy of Dermatology and Venereology : JEADV, 1998, Volume: 11, Issue:2

    Topics: Cyclosporine; Dermatologic Agents; Humans; Male; Middle Aged; Skin; Skin Diseases, Papulosquamous; Treatment Outcome

1998
Papuloerythroderma of Ofuji responding to treatment with cyclosporin.
    Clinical and experimental dermatology, 2000, Volume: 25, Issue:4

    Topics: Aged; Biopsy; Cyclosporine; Dermatitis, Exfoliative; Dermatologic Agents; Humans; Male; Precancerous Conditions; Skin Diseases, Papulosquamous; Treatment Outcome

2000